Ideaya Biosciences (IDYA) PT Raised to $40 at Oppenheimer
Oppenheimer analyst Matthew Biegler raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $40.00 (from $37.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)